DANVILLE, Pennsylvania: Using tens of thousands of records from its own volunteer patient biobank, officials at Geisinger and scientists at partner Regeneron Genetics Center discovered a gene variant that shows a significant reduction in the risk liver disease, a breakthrough discovery that could lead to uncharted treatment options.
The findings of the study were released on Thursday (Friday in Manila) in the New England Journal of Medicine.
Already have an active account? Log in here.
Continue reading with one of these options:
Continue reading with one of these options:
Premium + Digital Edition
Ad-free access
P 80 per month
(billed annually at P 960)
- Unlimited ad-free access to website articles
- Limited offer: Subscribe today and get digital edition access for free (accessible with up to 3 devices)
TRY FREE FOR 14 DAYS
See details
See details
If you have an active account, log in
here
.